| Product Code: ETC6661444 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Canada morphine market, the import trend experienced a significant decline from 2023 to 2024, with a growth rate of -46.48%. However, the compound annual growth rate (CAGR) for imports from 2020 to 2024 stood at a robust 71.6%. This drastic change in import momentum could be attributed to shifts in demand dynamics or alterations in trade policies impacting the market`s stability during that period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Morphine Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Morphine Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Morphine Market - Industry Life Cycle |
3.4 Canada Morphine Market - Porter's Five Forces |
3.5 Canada Morphine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada Morphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Canada Morphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring pain management, leading to higher demand for morphine. |
4.2.2 Growing awareness and acceptance of opioid analgesics for pain relief in Canada. |
4.2.3 Technological advancements in drug delivery systems improving the effectiveness and safety of morphine products. |
4.3 Market Restraints |
4.3.1 Stringent regulations and monitoring by health authorities to prevent misuse and abuse of morphine. |
4.3.2 Concerns regarding the addictive nature of opioids leading to hesitancy among healthcare providers and patients. |
5 Canada Morphine Market Trends |
6 Canada Morphine Market, By Types |
6.1 Canada Morphine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Morphine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Canada Morphine Market Revenues & Volume, By Oral Tablets, 2021- 2031F |
6.1.4 Canada Morphine Market Revenues & Volume, By Injection, 2021- 2031F |
6.1.5 Canada Morphine Market Revenues & Volume, By Capsule, 2021- 2031F |
6.1.6 Canada Morphine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Morphine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Canada Morphine Market Revenues & Volume, By Anesthesia, 2021- 2031F |
6.2.3 Canada Morphine Market Revenues & Volume, By Cough Suppressant, 2021- 2031F |
6.2.4 Canada Morphine Market Revenues & Volume, By Diarrhea Suppressant, 2021- 2031F |
7 Canada Morphine Market Import-Export Trade Statistics |
7.1 Canada Morphine Market Export to Major Countries |
7.2 Canada Morphine Market Imports from Major Countries |
8 Canada Morphine Market Key Performance Indicators |
8.1 Number of prescriptions for morphine-based products. |
8.2 Patient satisfaction levels with morphine therapy. |
8.3 Investment in research and development of new formulations or delivery methods for morphine. |
8.4 Education and training initiatives for healthcare professionals on appropriate opioid prescribing practices. |
8.5 Number of reported adverse events or incidents related to morphine use. |
9 Canada Morphine Market - Opportunity Assessment |
9.1 Canada Morphine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada Morphine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Canada Morphine Market - Competitive Landscape |
10.1 Canada Morphine Market Revenue Share, By Companies, 2024 |
10.2 Canada Morphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |